We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

FDA Seeks Feedback on Regulating Generative AI Medical Devices

By HospiMedica International staff writers
Posted on 28 Aug 2026

Generative artificial intelligence (AI) is rapidly entering clinical workflows, offering tools that could enhance patient care while introducing risks that differ from those of traditional software. More...

Hospitals and clinicians therefore need clear expectations for assessing safety and performance both before and after deployment. As these technologies continue to evolve, a coordinated regulatory framework will be essential. A new discussion paper outlines potential approaches for regulating generative AI-enabled medical devices and invites public feedback.

On August 18, 2026, the U.S. Food and Drug Administration (FDA) issued a discussion paper seeking feedback on considerations for regulating generative AI (GenAI)-enabled medical devices. The document is led by the Digital Health Center of Excellence (DHCoE) within the Center for Devices and Radiological Health (CDRH) and supports the agency’s Innovation and Global Leadership strategic pillar. The paper invites comment on risk assessment, premarket evaluation, postmarket monitoring, and other topics relevant to GenAI-enabled medical devices.

The paper proposes a possible two-axis framework for assessing risk and informing regulatory expectations. For premarket evaluation, it outlines a competency-based approach that draws broadly from physician training and combines non-clinical device benchmarking with clinical confirmation to verify performance before patient exposure. It also discusses risk-proportionate postmarket monitoring and addresses additional considerations for foundation models and agentic artificial intelligence systems.

To help shape a regulatory framework that is scientifically rigorous, prioritizes patient safety, and reflects the novel capabilities of GenAI-enabled devices, the agency poses targeted questions across each of these areas. Feedback is encouraged from device manufacturers, clinicians, consumers, researchers, the public, and other stakeholders. 

“Patients and clinicians deserve a regulatory approach that keeps pace with the rapid innovation of digital health technologies. By inviting input from the public, we are launching a transparent process to inform the development of an approach that safeguards patients and consumers, advances innovation, and serves as a potential model for regulators around the world,” said Michelle Tarver, M.D., Ph.D., Direcotr of the FDA Center for Devices and Radiological Health.

“Generative AI-enabled medical devices are poised to reshape the health technology landscape, and the FDA has an important responsibility to provide thoughtful leadership for this new era. This discussion paper advances the frontiers of regulatory science and propels a critical conversation about how to enable beneficial innovation, protect public health, and preserve trust,” said DHCoE Director Rick Abramson, M.D.

Related Links
Digital Health Center of Excellence


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Desk Aneroid Sphyg
Diagnostix 750D+
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: Shutterstock

AI-Derived Heart Age Linked to Cardiovascular and Dementia-Related Mortality

Cardiovascular disease is increasingly associated with dementia-related mortality and other forms of age-related decline. Identifying people with greater long-term vulnerability before severe outcomes... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.